Yongin-si, South Korea

Soo In Kim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Soo In Kim in Therapeutic Delivery Systems

Introduction

Soo In Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for therapeutic agents. His work focuses on enhancing the efficacy of drug delivery to specific organs, such as the liver.

Latest Patents

One of Soo In Kim's notable patents is titled "Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs." This patent discloses a composite with nanoscale particle size that is capable of specifically delivering therapeutic agents, including nucleic acids and drugs, to the liver. The composite is designed to selectively release these agents into hepatic cells, thereby manifesting potent therapeutic effects. The formulation may include an apolipoprotein A-1 and a liposome-forming material, along with a pharmaceutically acceptable carrier.

Career Highlights

Soo In Kim is affiliated with the Mogam Biotechnology Research Institute, where he continues to advance research in biotechnology and therapeutic delivery systems. His innovative approaches have garnered attention in the scientific community, contributing to the development of more effective treatment options.

Collaborations

Soo In Kim collaborates with several talented individuals in his field, including Meehyein Kim and Duckhyang Shin. These collaborations enhance the research and development efforts at the Mogam Biotechnology Research Institute.

Conclusion

Soo In Kim's work in the field of therapeutic delivery systems exemplifies the potential of biotechnology to improve medical treatments. His innovative patent on liver-specific delivery systems highlights the importance of targeted therapies in enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…